Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay
about
Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-AnalysisBleeding risks with novel oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and network meta-analysis.New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interruptedEfficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-AnalysisThe role of novel anticoagulants in the management of venous thromboembolic disease.Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.Practical issues in the management of novel oral anticoagulants-cardioversion and ablation.Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation.Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review.Atrial Fibrillation and Stroke - Increasing Stroke Risk With Intervention.Atrial Fibrillation and Stroke: Increasing Stroke Risk with InterventionAtrial Fibrillation and Stroke - Increasing Stroke Risk With Intervention.Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation.New oral anticoagulants in patients undergoing atrial flutter radiofrequency catheter ablation: an observational study.Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.Safety and efficacy of novel oral anticoagulants in the setting of atrial fibrillation ablation: Is it time to celebrate the "funeral" of warfarin?Periprocedural dabigatran anticoagulation for atrial fibrillation ablation: do we have enough information to make a rational decision
P2860
Q32177661-1353FFB1-6B83-4D38-9CD3-31EDA8541AA3Q35631782-4779DEB4-ADCF-46DB-9940-16358E1C921BQ35765335-498ED208-5F14-4662-A255-CC021D21F6DBQ36247011-75F4CF17-7BBC-4E11-99AB-264CEE4708E9Q36999959-CC65DCBC-4438-408B-B76D-1AF7DB7E2712Q38218874-42F0192F-77CF-45CE-8102-1F3515FC0765Q38248656-4B2BAC81-B277-472B-A2E6-B4469FF1BE7AQ38365022-3D332CAE-4BC7-4AB0-B29A-43A559F4ADB7Q38398014-D17D6592-98B9-4375-B3EF-630B917650F0Q38496232-69703604-1798-4740-A861-682372E59CDAQ38541307-99C2A878-2D4C-48A7-9C90-B9D93BB8CF77Q38790283-E8602E38-89F3-4515-B368-D0C8001DB6E7Q38804132-E98674E1-5B12-4602-AEFC-7A5B71C25705Q38810698-67638870-FCEF-4A92-92FC-F31A33EE7A7CQ38826010-04067B61-BBC2-4D18-88F1-2BFEBBF61FA5Q39078015-A02D50E0-F7FD-478E-8528-3E24D0F942F6Q39900127-667A8730-394C-4566-BC05-76AC3F2E261CQ48537715-EBC2A3A3-2F0E-4498-BA67-774137A0B1F8Q58479713-C711D600-A544-4737-B508-3459B0B39283
P2860
Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dabigatran in the peri-procedu ...... t on duration of hospital stay
@en
Dabigatran in the peri-procedu ...... on duration of hospital stay.
@nl
type
label
Dabigatran in the peri-procedu ...... t on duration of hospital stay
@en
Dabigatran in the peri-procedu ...... on duration of hospital stay.
@nl
prefLabel
Dabigatran in the peri-procedu ...... t on duration of hospital stay
@en
Dabigatran in the peri-procedu ...... on duration of hospital stay.
@nl
P2093
P2860
P1476
Dabigatran in the peri-procedu ...... t on duration of hospital stay
@en
P2093
Akihiro Yoshida
Akinori Matsumoto
Asumi Takei
Atsushi Suzuki
Kaoru Takami
Ken-Ichi Hirata
Kimitake Imamura
Koji Fukuzawa
Kunihiko Kiuchi
Mitsuaki Itoh
P2860
P2888
P304
P356
10.1007/S10840-013-9801-Y
P577
2013-04-14T00:00:00Z